VRTX Edward Morrow Atkinson III sells $1.3M worth of shares
Mar 27, 2025, 10:31 AM
0.00%
What does VRTX do
Vertex Pharmaceuticals, headquartered in Boston, specializes in developing small molecule drugs for serious diseases, with four approved cystic fibrosis treatments and therapies for sickle cell disease. The company employs 5,400 people and explores innovative treatments for various conditions, including type 1 diabetes.
Edward Morrow Atkinson III sold 2,650 shares of VRTX on 27 February at $475.34 per share, worth a total of $1.3M. They now own 19,352 VRTX shares, or a 12% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.